Table 2.
Variable | n (% Unless Otherwise Indicated) |
---|---|
Body weight 1 | |
Underweight (Body Mass Index (BMI) < 18.5) | 21 (1.2%) |
Normal weight (BMI 18.5–24.9) | 388 (22.9%) |
Overweight and obesity (all) | 1282 (75.9%) |
Overweight (BMI 25–29.9) | 512 (30.3%) |
Obesity I (BMI 30–34.9) | 422 (24.9%) |
Obesity II (BMI 35–39.9) | 231 (13.7%) |
Extreme Obesity (BMI ≥ 40) | 118 (7.0%) |
Waist circumference above 88 cm | 988 (58.3%) |
Low High-density lipoprotein (<50 mg/dL) | 445 (28.6%) |
Triglycerides ≥ 150 mg/dL | 449 (28.8%) |
Mean fasting blood glucose level in patients without impaired fasting glucose or diabetes (mg/dL) (SD) 2 | 87.98 (11.20) |
Patients with diabetes n (%) | 193 (11.4%) |
On medication n (%) | 177 (91.7%) |
Patients with impaired fasting glucose 2 | 358 (22.9%) |
Fasting Blood Glucose (FBG) ≥ 110 mg/dL with/without medication | 332 (21.2%) |
Normal FBG (FBG < 110 mg/dL) on diabetes treatment | 26 (1.7%) |
Hypertension (≥140 mm Hg systolic or ≥90 mm Hg diastolic 3 and/or take medication) | 200 (11.8%) |
Metabolic syndrome 4 | |
Based on the definition of the World Health Organization | 262 (16.9%) |
Based on the definition of The Adult Treatment Panel III | 415 (26.6%) |
1 Data based on 1692 out of 1694 women. 2 Estimate based on 1562 out of 1694 women. 3 Estimate based on 1692 out of 1694 women. 4 Estimate based on 1552 out of 1694 women.